Literature DB >> 26978646

Efficient Absorption of X-Hydroxyproline (Hyp)-Gly after Oral Administration of a Novel Gelatin Hydrolysate Prepared Using Ginger Protease.

Yuki Taga1, Masashi Kusubata1, Kiyoko Ogawa-Goto1, Shunji Hattori1.   

Abstract

Recent studies have reported that oral intake of gelatin hydrolysate has various beneficial effects, such as reduction of joint pain and lowering of blood sugar levels. In this study, we produced a novel gelatin hydrolysate using a cysteine-type ginger protease having unique substrate specificity with preferential peptide cleavage with Pro at the P2 position. Substantial amounts of X-hydroxyproline (Hyp)-Gly-type tripeptides were generated up to 2.5% (w/w) concomitantly with Gly-Pro-Y-type tripeptides (5%; w/w) using ginger powder. The in vivo absorption of the ginger-degraded gelatin hydrolysate was estimated using mice. The plasma levels of collagen-derived oligopeptides, especially X-Hyp-Gly, were significantly high (e.g., 2.3-fold for Glu-Hyp-Gly, p < 0.05) compared with those of the control gelatin hydrolysate, which was prepared using gastrointestinal proteases and did not contain detectable X-Hyp-Gly. This study demonstrated that orally administered X-Hyp-Gly was effectively absorbed into the blood, probably due to the high protease resistance of this type of tripeptide.

Entities:  

Keywords:  LC−MS; absorption; collagen; gelatin hydrolysate; ginger; hydroxyproline

Mesh:

Substances:

Year:  2016        PMID: 26978646     DOI: 10.1021/acs.jafc.6b00609

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  8 in total

Review 1.  Role of corneal collagen fibrils in corneal disorders and related pathological conditions.

Authors:  Hong-Yan Zhou; Yan Cao; Jie Wu; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

2.  Identification of a highly stable bioactive 3-hydroxyproline-containing tripeptide in human blood after collagen hydrolysate ingestion.

Authors:  Yuki Taga; Yu Iwasaki; Chisa Tometsuka; Noriko Funato; Yasutaka Shigemura; Masashi Kusubata; Kazunori Mizuno
Journal:  NPJ Sci Food       Date:  2022-06-03

3.  The Influence of Specific Bioactive Collagen Peptides on Body Composition and Muscle Strength in Middle-Aged, Untrained Men: A Randomized Controlled Trial.

Authors:  Denise Zdzieblik; Patrick Jendricke; Steffen Oesser; Albert Gollhofer; Daniel König
Journal:  Int J Environ Res Public Health       Date:  2021-04-30       Impact factor: 3.390

4.  Non-targeted and targeted analysis of collagen hydrolysates during the course of digestion and absorption.

Authors:  Anne J Kleinnijenhuis; Frédérique L van Holthoon; Annet J H Maathuis; Barbara Vanhoecke; Janne Prawitt; Fabien Wauquier; Yohann Wittrant
Journal:  Anal Bioanal Chem       Date:  2019-12-24       Impact factor: 4.142

5.  The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial.

Authors:  Denise Zdzieblik; Judith Brame; Steffen Oesser; Albert Gollhofer; Daniel König
Journal:  Nutrients       Date:  2021-02-05       Impact factor: 5.717

6.  Long-term intake of ginger protease-degraded collagen hydrolysate reduces blood lipid levels and adipocyte size in mice.

Authors:  Chisa Tometsuka; Noriko Funato; Kazunori Mizuno; Yuki Taga
Journal:  Curr Res Food Sci       Date:  2021-03-24

7.  Evaluating the Properties of Ginger Protease-Degraded Collagen Hydrolysate and Identifying the Cleavage Site of Ginger Protease by Using an Integrated Strategy and LC-MS Technology.

Authors:  Wei Liu; Wenning Yang; Xueyan Li; Dongying Qi; Hongjiao Chen; Huining Liu; Shuang Yu; Guopeng Wang; Yang Liu
Journal:  Molecules       Date:  2022-08-06       Impact factor: 4.927

8.  A Pilot Study for the Detection of Cyclic Prolyl-Hydroxyproline (Pro-Hyp) in Human Blood after Ingestion of Collagen Hydrolysate.

Authors:  Yasutaka Shigemura; Yu Iwasaki; Mana Tateno; Asahi Suzuki; Mihoko Kurokawa; Yoshio Sato; Kenji Sato
Journal:  Nutrients       Date:  2018-09-22       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.